New Eyelash Drug Approved
Posted on: Saturday, 27 December 2008, 10:45 CST
On Friday, Allergan Inc., the maker of Botox, said that the U.S. Food and Drug Administration had approved its eyelash-thickening drug Latisse.
Latisse is designed to treat a condition known as hypotrichosis of the eyelashes, which makes a person not have enough eyelashes.
Bimatroprost is the active ingredient in Latisse, which is the same ingredient that is in Allergan's glaucoma treatment, Lumigan. The patients taking Lumigan said that it made their eyelashes grow, leading Allergan to study it for the new use.
Latisse is to be taken once-daily by applying it to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
